160 HEALTH (02656) has announced that the group is progressively implementing a "Digital Medical Staff" system for medical institutions, leveraging its integrated model of "Platform + AI Agents + Operations." This initiative promotes the application of AI agents, represented by OpenClaw, within medical settings. Specifically, the group embeds AI agents throughout the entire patient journey—pre-consultation, during consultation, and post-consultation. Through multi-agent collaboration, these systems are applied in patient management, health education, high-value health service operations, automated medical record generation, intelligent medical insurance accounting, and departmental ledger management. The objective is to reduce the administrative workload of medical staff, allowing them to focus more on core diagnostic and treatment duties.

While empowering external partners, the group has also fully integrated AI agents into its internal operations. These are currently utilized in product development, content creation, and customer service systems, leading to a reduction of over 60% in the product iteration cycle. Furthermore, the group has completed the deployment of OpenClaw and continues to refine its related applications. The resulting internal efficiency gains have significantly accelerated the speed of deployment and delivery for medical institutions.

The group consistently adheres to a safety-first principle. All externally applied and internally deployed AI agents undergo comprehensive, end-to-end security reinforcement by an internal professional technical team to ensure safe and stable system operation. Moving forward, the group will utilize its authentic doctor-patient interaction scenarios and mature platform operational capabilities to continue exploring deeper applications of AI agents like OpenClaw in the healthcare sector, committed to creating long-term value for shareholders.